Radiopharmaceuticals Market Size, Scope, and Share by 2031
Radiopharmaceuticals Market: Size and Share
-
CAGR (2023 - 2031)14.4% -
Market Size 2023
US$ 9.07 Billion -
Market Size 2031
US$ 26.51 Billion
Market Dynamics
- Rising Prevalence of Chronic Diseases
- Growing Number of Clinical Trials in Targeted Therapy
- Short Shelf-Life of Radiopharmaceuticals
- High Growth Potential in Developing Countries
Market Segmentation
Application - Oncology
- Cardiology
- Neurology
- Pulmonary
- Urology
Type - Diagnostic
- Therapeutic
Tracer Type - Tc-99m
- F-18
- Ga-68
- TL-201
- I-131
- Fe-59
- Lu-171
- RB-82 and N-13
- Cr-51 and P-32
- Sc-46
- Sg-269 and Hs-269
End User - Hospitals and Clinics
- Diagnostic Centers
- Academic and Research Institutes
Radiopharmaceuticals Market Players Density: Understanding Its Impact on Business Dynamics
The Radiopharmaceuticals Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.
Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.
Major Companies operating in the Radiopharmaceuticals Market are:
- Medi-Radiopharma (MRP),
- Rotem Industries Ltd.,
- ABX Advanced Biochemical Compounds GmbH,
- Invicro LLC,
- Cardinal Health,
- Newcastle University,
Disclaimer: The companies listed above are not ranked in any particular order.
- Get the Radiopharmaceuticals Market top key players overview
Get Free Sample For